GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹5,918 Cr | ₹5,218 Cr | ₹4,247 Cr | ₹6,172 Cr | ₹5,270 Cr |
What is the latest Net Current Assets ratio of GLAND PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹5,918 Cr |
| Mar2025 | ₹5,218 Cr |
| Mar2024 | ₹4,247 Cr |
| Mar2023 | ₹6,172 Cr |
| Mar2022 | ₹5,270 Cr |
How is Net Current Assets of GLAND PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,918 Cr | 13.42 | |
| Mar2025 | ₹5,218 Cr | 22.87 | |
| Mar2024 | ₹4,247 Cr | -31.19 | |
| Mar2023 | ₹6,172 Cr | 17.11 | |
| Mar2022 | ₹5,270 Cr | - | |
Compare Net Current Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,384.6 Cr | 1.5% | 12% | 55.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 1.5% |
12% |
55.4% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses